344 related articles for article (PubMed ID: 18035510)
1. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
[TBL] [Abstract][Full Text] [Related]
2. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
[TBL] [Abstract][Full Text] [Related]
3. Increase of cellular recruitment, phagocytosis ability and nitric oxide production induced by hydroalcoholic extract from Chenopodium ambrosioides leaves.
Cruz GV; Pereira PV; Patrício FJ; Costa GC; Sousa SM; Frazão JB; Aragão-Filho WC; Maciel MC; Silva LA; Amaral FM; Barroqueiro ES; Guerra RN; Nascimento FR
J Ethnopharmacol; 2007 Apr; 111(1):148-54. PubMed ID: 17156956
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB/c mice, caused by Leishmania amazonensis.
Monzote L; García M; Montalvo AM; Linares R; Scull R
Forsch Komplementmed; 2009 Oct; 16(5):334-8. PubMed ID: 19887812
[TBL] [Abstract][Full Text] [Related]
5. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
7. Antileishmanial activity of essential oil from Chenopodium ambrosioides and its main components against experimental cutaneous leishmaniasis in BALB/c mice.
Monzote L; Pastor J; Scull R; Gille L
Phytomedicine; 2014; 21(8-9):1048-52. PubMed ID: 24768411
[TBL] [Abstract][Full Text] [Related]
8. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment.
Nascimento FR; Cruz GV; Pereira PV; Maciel MC; Silva LA; Azevedo AP; Barroqueiro ES; Guerra RN
Life Sci; 2006 Apr; 78(22):2650-3. PubMed ID: 16307762
[TBL] [Abstract][Full Text] [Related]
9. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis.
Monzote L; Montalvo AM; Almanonni S; Scull R; Miranda M; Abreu J
Chemotherapy; 2006; 52(3):130-6. PubMed ID: 16636536
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
Sadeghian G; Nilfroushzadeh MA; Iraji F
Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the subchronic toxicity of oral treatment with Chenopodium ambrosioides in mice.
Pereira WS; Ribeiro BP; Sousa AI; Serra IC; Mattar NS; Fortes TS; Reis AS; Silva LA; Barroqueiro ES; Guerra RN; Nascimento FR
J Ethnopharmacol; 2010 Feb; 127(3):602-5. PubMed ID: 20026398
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
Nilforoushzadeh MA; Shirani-Bidabadi L; Zolfaghari-Baghbaderani A; Saberi S; Siadat AH; Mahmoudi M
J Vector Borne Dis; 2008 Dec; 45(4):301-6. PubMed ID: 19248657
[TBL] [Abstract][Full Text] [Related]
13. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
Shazad B; Abbaszadeh B; Khamesipour A
Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
[TBL] [Abstract][Full Text] [Related]
14. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A
Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
[TBL] [Abstract][Full Text] [Related]
16. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL
J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238
[TBL] [Abstract][Full Text] [Related]
17. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
18. In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.
Fournet A; Ferreira ME; Rojas De Arias A; Torres De Ortiz S; Fuentes S; Nakayama H; Schinini A; Hocquemiller R
Antimicrob Agents Chemother; 1996 Nov; 40(11):2447-51. PubMed ID: 8913444
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
Salmanpour R; Razmavar MR; Abtahi N
Int J Dermatol; 2006 Sep; 45(9):1115-6. PubMed ID: 16961529
[No Abstract] [Full Text] [Related]
20. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
